884500-75-8

Usage

Molecular structure

A heterocyclic compound with a pyrano-pyridone structure, containing a pyran ring fused to a pyridine ring.

Functional groups

3-fluoro-4-hydroxy-phenyl group attached to the pyrano-pyridone core.

Potential biological activities

The compound is being studied for its therapeutic properties, particularly in the field of medicinal chemistry and drug development.

Structure-activity relationships

Of interest for understanding the relationship between the compound's structure and its potential applications in various industries.

Heterocyclic nature

The compound consists of both carbon and non-carbon atoms (such as nitrogen and oxygen) in its ring structure.

Potential applications

Due to its unique structure and properties, the compound may have potential uses in pharmaceuticals, agrochemicals, or other industries.

Upstream product

• 67367-26-4 2-methoxynicotinic acid methyl ester 
• 1452-94-4 ethyl 2-chloronicotinate 
• 884501-78-4 1-(3-fluoro-4-methoxyphenyl)-3-(2-methoxypyridin-3-yl)propane-1,3-dione 

Relevant academic research and scientific papers

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of cancer as well as sepsis

Synthesis of 2-aryl-4H-pyrano[2,3-b]pyridin-4-ones by a one-pot deprotection-cyclization reaction

An efficient synthesis of 2-aryl-4H-pyrano[2,3-b]pyridine-4-ones is reported, using a one-pot, two step process in the presence of pyridinium hydrochloride. The methodology is compatible with a series of functional groups useful for the synthesis of secon

PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF COMPLEX DISEASES AND THEIR DELIVERY BY INSERTABLE MEDICAL DEVICES

The present invention relates to polyphenol-like compounds that are useful for inhibiting VCAM-1 expression, MCP-1 expression and/or SMC proliferation in a mammal. The disclosed compounds are useful for regulating markers of inflammatory conditions, including vascular inflammation, and for treatment and prevention of inflammatory and cardiovascular diseases and related disease states.